# Resonant Clinical Solutions and Haier Biomedical Introduce an Innovative Benchtop Centrifuge with a Natural Refrigerant

- Link: https://www.thailand-business-news.com/pr-news/resonant-clinical-solutions-and-haier-biomedical-introduce-an-innovative-benchtop-centrifuge-with-a-natural-refrigerant
- Published: 2026-10-07T19:30:00+07:00
- Author: PR Newswire

_Exclusive partnership results in a user-centric, hydrocarbon-cooled centrifuge 
purpose-built for clinical trials – years ahead of upcoming F-gas regulatory changes
in Europe and the U.S._

LEESBURG, Va. and QINGDAO, China, Oct. 7, 2026 /PRNewswire/ — Resonant Clinical 
Solutions – a global clinical solutions partner serving life sciences organizations
across the clinical supply chain and sample lifecycle – and Haier Biomedical – a
trusted leader in reliable and sustainable laboratory equipment – have launched 
an innovative benchtop centrifuge using a natural refrigerant. The hydrocarbon-cooled
LX-60T100R is specifically designed for clinical trials use, with new features that
reduce its environmental impact and overcome constraints that have previously limited
equipment in this category. The reengineered centrifuge is the result of an ongoing
partnership between the two companies.

[⌊Resonant-Haier Biomedical Partnership Logo Lockup⌉⌊Resonant-Haier Biomedical Partnership
Logo Lockup⌉[
Resonant-Haier Biomedical Partnership Logo Lockup

The strategic collaboration combined Haier Biomedical’s engineering expertise with
Resonant’s clinical trials knowledge to create a modern, user-centric instrument.
Importantly, the centrifuge complies with upcoming legislation further restricting
the use of fluorinated greenhouse gases (F-gases) – historically used as refrigerants
in laboratory instruments – due to their significant global warming potential (GWP).
The jointly developed centrifuge directly addresses this challenge, and is available
more than two years ahead of critical industry deadlines in Europe and the U.S.

The LX-60T100R meets the demanding needs of pharmaceutical sponsors and contract
research organizations (CROs), helping them to prepare for upcoming regulation changes
and deliver on corporate environmental sustainability commitments while enhancing
safety, reliability, and ease of use.

Key features of the LX-60T100R include:

 ◦ **Natural hydrocarbon (R290) refrigerant**, substantially lowering environmental
   impact compared to legacy F-gas systems
 ◦ **Rapid pre-cooling** from room temperature to 4 °C in approximately five minutes,
   reducing the wait times associated with legacy refrigerated centrifuges
 ◦ **Speed and rotor profile matched to routine clinical trial workflows**, such
   as blood collection tubes, 15 and 50 mL conical flasks, and bottles up to 100
   mL
 ◦ **Advanced 7-inch LCD touchscreen** with multi-point touch control that is responsive
   even with gloves, on-screen calibration and configuration, RFID rotor recognition,
   user log-in controls, and storage for over 1,000 programs
 ◦ **Built-in safety and reliability monitoring**, with vibration and imbalance 
   detection, level check, rotor-life tracking and warning, and an ultra-low center
   of gravity that limits vibration
 ◦ **Quiet, lab-friendly operation**, as low as 52 dB(A) in fixed-angle rotor configurations,
   suited to shared lab environments and long processing runs
 ◦ **Weighs ~46 kg and fits on a standard laboratory bench** without special floor
   mounting, reinforced surfaces or dedicated space
 ◦ **Significantly reduces refrigerant GWP** from more than 1,400 in legacy F-gas
   systems to approximately 3,* without compromising cooling performance

Christophe Berthoux, Chief Executive Officer at Resonant Clinical Solutions, said:"
We are laser-focused on providing world-class, customer-centric solutions that support
the full lifecycle of complex clinical trial programs. Our collaboration with Haier
Biomedical on this reimagined natural-refrigerant centrifuge has been pivotal in
delivering innovative, globally supported technology that meets F-gas regulatory
requirements and market demand, years ahead of mandated deadlines. Clinical trial
centrifugation workflows will be easier, more flexible, and more environmentally
sustainable with this industry-leading instrument."

Haier Biomedical’s Co-Chief Executive Officer, Gang Liu, added: "Our ability to 
turn a concept into an innovative product in such a short period really shows our
commitment to supporting our customers. Fresh challenges will continue to emerge
across the biomedical sector, and we remain dedicated to working alongside scientists
to develop novel solutions that help the industry move forward at pace. In this 
instance, the partnership with Resonant resulted in a modern, easy-to-use, and regulatory-
compliant centrifuge that significantly enhances workflows while reducing the use
of harmful greenhouse gases."

Clinical trial sponsors and CROs can purchase or rent the LX-60T100R refrigerated
centrifuge exclusively from Resonant** through November 2027. The 220–240 V AC, 
50/60 Hz model is immediately available for purchase or rental, with the 110 V AC,
50/60 Hz model launching in Q1 2027. More information can be obtained at [resonantclinical.com/products/centrifuges](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4791065-1&h=668673461&u=https%3A%2F%2Fmesm.resonantclinical.com%2Fproducts%2Fcentrifuges%2Flx-60t100r%2F&a=resonantclinical.com%2Fproducts%2Fcentrifuges).

* GWP measures a gas’s climate impact relative to CO₂, which has a GWP of 1. A GWP
of 1,000 therefore has around 1,000 times the warming impact of CO₂, while a GWP
of 3 has around three times the impact.
** Exclusivity agreement covers the clinical
trials market worldwide, excluding China.

**About Resonant Clinical SolutionsResonant Clinical Solutions is a global clinical
solutions partner serving life sciences organizations across the clinical supply
chain and sample lifecycle. Through its Biorepository, Kitting, and Equipment & 
Ancillaries businesses, Resonant helps customers manage complexity, reduce risk,
and support critical clinical programs around the world. With more than 850 employees
across the U.S., U.K., and Europe, Resonant manages more than 100 million research
assets in storage, and has supported more than 2,500 clinical trials and facilitated
more than 20,000 customer-site shipments. The company serves pharmaceutical and 
biotechnology companies, contract research organizations (CROs), contract development
and manufacturing organizations (CDMOs), and diagnostic and reference laboratories.

Resonant’s mission is to empower its partners with comprehensive, global clinical
supply chain and sample lifecycle solutions that remove complexity and enable them
to focus on science and patients. For more information, visit [resonantclinical.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4791065-1&h=1312199997&u=https%3A%2F%2Fresonantclinical.com%2F&a=resonantclinical.com).

**About Haier BiomedicalHaier Biomedical is a global life sciences and medical technology
company developing intelligent, connected and sustainable solutions for healthcare,
research and public health. Established in 2005 and listed on the Shanghai Stock
Exchange STAR Market, the company operates across more than 160 countries and regions
through a global network spanning research, user experience, marketing, logistics,
technical training and more than 800 distribution partners. From biobanking and 
smart laboratories to pharmacy, blood management and public health, Haier Biomedical
combines technological innovation with close collaboration with customers, partners
and end users. This combination of global capabilities and local-market insights
enables the company to turn real-world needs into practical solutions that improve
efficiency, resilience and outcomes across the life sciences and healthcare ecosystems.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Resonant Clinical Solutions and Haier Biomedical Introduce an Innovative Benchtop Centrifuge with a Natural Refrigerant ](http://www.prnasia.com/story/archive/5065224_AE65224_0?rand=184833)
